AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net buying: insiders sold $0 and bought $30K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$30K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $6.37
- 52-wk high
- $9.62
- High
- $6.45
- 52-wk low
- $3.53
- Low
- $6.08
- Prev close
- $6.24
- Mkt cap
- $170.6M
- Volume
- 154.2K
- Fwd P/E
- 11.8x
- Beta
- 1.25
- P/S
- 3.8x
- P/B
- 3.9x
- Profit margin
- -117.0%
- Op margin
- -80.8%
- ROE
- -135.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about DTIL filings
Are insiders buying or selling Precision BioSciences Inc (DTIL) stock?
Net buying: insiders sold $0 and bought $30K of DTIL stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was Germano, Geno J (Director), who bought $16K. The latest filing was on Sep 30, 2026.
Which members of Congress have traded DTIL recently?
None. No member of Congress disclosed a DTIL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this DTIL smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (3)
- FS
Frankel Stanley
$6K
bought
- GG
Germano Geno J
$16K
bought
- BM
Brown Melinda
$7K
bought
How top traders are positioned
No tracked top-trader positions in DTIL right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 4.1% above what analysts expected.
Earnings per share
-$0.74 expected
Reports Nov 2, 2026, in 32 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -117.0%
- Forward P/E
- 11.78
- Market cap
- $171M
Valuation
- P/S3.79
- P/B3.88
Quality
- Operating margin-80.8%
- ROE-135.1%
- ROA-19.4%
Growth
- Beta1.25
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Macro
10 macro signals shaping DTIL right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results